Skip to main content
    P

    Profound Medical Corp (PROF)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $7.08
    -0.26 (-3.54%)

    Market Cap: $268.84M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Profound Medical Corp (PROF) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Profound Medical (PROF) has a market cap of $268.84M and an enterprise value of $240.01M. It kept -137.51% of revenue as net income over the last 12 months. Its share count is up 21.43% from a year earlier.

    Total Valuation

    Enterprise value is 10.72% below the market cap, as cash exceeds debt.

    Market Cap$268.84M
    Enterprise Value$240.01M
    Latest price (Nov 17, 2026)$7.08

    Key Dates

    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.57% in the quarter ended Sep 30, 2026 and grew 21.80% a year over 2 years.

    Shares Outstanding36.56M
    Shares Change (YoY)+21.43%
    Shares Change (QoQ)+0.57%
    Share Count Growth (2Y CAGR)+21.80%

    Valuation Ratios

    Sales and book value multiples are 11.0x and 6.1x. Its year-end P/S ranged from 8.6x to 46.4x from 2017 to 2025.

    P/S Ratio11.0x
    Forward P/S7.5x
    P/B Ratio6.1x
    P/TBV Ratio6.1x

    Valuation history and multiples

    Price Statistics

    The stock is up 3.36% over 52 weeks and trades 12.03% above its 50-day average.

    Beta (1Y)1.41
    52-Week Change+3.36%
    1-Month Change+20.82%
    6-Month Change+5.20%
    5-Year Change-51.37%
    10-Year Change-17.36%
    Total Return (1Y)+3.36%
    Total Return (3Y CAGR)-12.75%
    Total Return (5Y CAGR)-9.93%
    Return vs SPY (1Y)+2.08%
    Max Drawdown (1Y)-41.50%
    Max Drawdown (3Y)-65.38%
    Sharpe Ratio (1Y)0.18
    Correlation with SPY (1Y)0.28
    50-Day Average$6.32
    200-Day Average$6.64
    52-Week Range$4.80 to $8.95
    RSI (14 Days)55.1
    Average Volume (20 Days)196.07K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.54x current liabilities, and total debt is 0.11x shareholder equity.

    Current Ratio4.54x
    Quick Ratio3.70x
    Debt / Equity0.11x

    Returns and Efficiency

    Return on invested capital is -71.15% over the last 12 months, against a 5-year average of -54.99%.

    Return on Equity (ROE)-76.42%
    Return on Assets (ROA)-55.87%
    Return on Invested Capital (ROIC)-71.15%
    ROA (5Y Average)-47.77%
    ROIC (5Y Average)-54.99%
    Asset Turnover0.47x
    Inventory Turnover0.60x
    Receivables Turnover2.29x
    Cash Conversion Cycle712 days

    Scores

    PROF has an Altman Z-Score of 1.81, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score1.81
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $23.63M over the last 12 months is up 65.26% from the 12 months before.

    Revenue$23.63M
    Revenue Growth (YoY)+65.26%
    Gross Profit$17.45M
    Operating Income-$34.28M
    Pretax Income-$32.39M
    Net Income-$32.49M
    Reported EPS (TTM)-$0.41

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 73.10% of the $58.15M in total assets.

    Cash and Equivalents$33.34M
    Total Debt$4.51M
    Net Cash$28.83M
    Net Cash Per Share$0.79
    Working Capital$42.77M
    Shareholder Equity$42.51M
    Book Value Per Share$1.16
    Tangible Book Value$42.40M
    Tangible Book Per Share$1.16
    Total Assets$58.15M
    Total Liabilities$15.64M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$31.49M
    FCF Per Share-$0.87
    Depreciation and Amortization$477.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -145.08%.

    Gross Margin73.86%
    Operating Margin-145.08%
    Pretax Margin-137.08%
    Net Margin-137.51%
    Gross Margin (5Y Average)56.95%

    Growth

    Revenue grew 34.06% a year over 3 years.

    Revenue Growth (3Y CAGR)+34.06%
    Revenue Growth (5Y CAGR)+17.12%
    Book Value Per Share Growth (2Y CAGR)+21.65%
    Tangible Book Per Share Growth (2Y CAGR)+22.49%

    Revenue and profit by year

    Dividends and Yields

    PROF does not pay a dividend.

    Buyback Yield-16.40%
    Shareholder Yield-16.40%

    Stock Splits

    The last split was a 1-for-10 reverse split on Oct 16, 2019.

    Last Split DateOct 16, 2019
    Split TypeReverse split
    Split Ratio1:10

    Analyst Forecast

    Consensus estimates put revenue growth at 94.75% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+94.75%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PROF

    What is PROF's market cap?

    Profound Medical has a market cap of $268.84M. Its enterprise value, which adds debt and subtracts cash, is $240.01M.

    How many shares of PROF are outstanding?

    Profound Medical has 36.56M shares outstanding. The count is up 21.43% from a year earlier.

    Does PROF pay a dividend?

    No. Profound Medical does not pay a dividend.

    How much debt does PROF have?

    Profound Medical has $4.51M of total debt and $33.34M of cash and equivalents, a net cash position of $28.83M.